Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.
Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its potent immunosuppressive properties and possesses impor...
Main Authors: | Anoop M Nambiar, Antonio R Anzueto, Jay I Peters |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5404863?pdf=render |
Similar Items
-
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2011-01-01) -
Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis
by: Obrenčević Katarina, et al.
Published: (2007-01-01) -
The Effectiveness and Safety of Mycophenolate Mofetil in Lupus Nephritis
by: Elyan, Mazen
Published: (2008) -
Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01) -
Mycophenolate mofetil in the treatment of lupus nephritis
by: Patrick FK Yong, et al.
Published: (2008-06-01)